Cargando…
First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function
SIMPLE SUMMARY: About 40% of people diagnosed with cancer are eligible for treatment with checkpoint inhibitors (CPIs). Little research has been conducted to understand whether CPIs affect cognitive function. Most research that has been conducted included patients who received both CPIs and chemothe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000599/ https://www.ncbi.nlm.nih.gov/pubmed/36900405 http://dx.doi.org/10.3390/cancers15051615 |